The policy change would affect artificial hearts and ventricular assist devices, which are used to treat patients with advanced heart failure. Currently, Medicare only covers these artificial heart devices when beneficiaries are enrolled in a clinical study.
Under the new policy, artificial hearts could be covered without being linked to a clinical study. Coverage determinations for artificial hearts would be made by local Medicare Administrative Contractors.
CMS said while a small number of Medicare patients receive artificial hearts, the proposed coverage expansion would treat end-stage heart disease without causing delays.
Read more here.
More articles on payers:
Fraudulent coding led CMS to overpay Cigna $1.4B, Justice Department says
Lawmakers to probe health insurer profits
5 payers that made $1B+ in Q2
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.